Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Body mass index and lung cancer risk in never smokers: a meta-analysis

Authors: Hongjun Zhu, Shuanglin Zhang

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Obesity is found to increase the risk of most cancer types, but reduce lung cancer risk in many studies. However, the association between obesity and lung cancer is still controversial, mainly owing to the confounding effect of smoking.

Methods

Eligible studies were identified from electric databases to July 1, 2017. Relevant data were extracted and pooled using random-effects models; dose-response and subgroup analyses were also performed.

Results

Twenty-nine studies with more than 10,000 lung cancer cases in15 million never smokers were included. Compared with normal weight, the summary relative risk (RR) was 0.77(95% confidence interval [CI]: 0.68–0.88, P < 0.01) for excess body weight (body mass index [BMI] ≥ 25 kg/m2). An inverse linear dose-response relationship was observed between BMI and lung cancer risk in never smokers, with an RR of 0.89(95% CI: 0.84–0.95, P < 0.01) per 5 kg/m2 increment in BMI. The results remained stable in most subgroup analyses. However, when stratified by sex, a significant inverse association existed in women but not in men. Similar results were found in analyses for other categories of BMI.

Conclusion

Our results indicate that higher BMI is associated with lower lung cancer risk in never smokers.
Appendix
Available only for authorised users
Literature
1.
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRefPubMed
2.
Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384(9945):755–65.CrossRefPubMedPubMedCentral
3.
Parr CL, Batty GD, Lam TH, Barzi F, Fang X, Ho SC, Jee SH, Ansary-Moghaddam A, Jamrozik K, Ueshima H, et al. Body-mass index and cancer mortality in the Asia-Pacific cohort studies collaboration: pooled analyses of 424,519 participants. Lancet Oncol. 2010;11(8):741–52.CrossRefPubMedPubMedCentral
4.
Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74.CrossRefPubMedPubMedCentral
5.
6.
Knekt P, Heliovaara M, Rissanen A, Aromaa A, Seppanen R, Teppo L, Pukkala E. Leanness and lung-cancer risk. Int J Cancer. 1991;49(2):208–13.CrossRefPubMed
7.
Henley SJ, Flanders WD, Manatunga A, Thun MJ. Leanness and lung cancer risk: fact or artifact? Epidemiology. 2002;13(3):268–76.CrossRefPubMed
8.
El-Zein M, Parent ME, Rousseau MC. Comments on a recent meta-analysis: obesity and lung cancer. Int J Cancer. 2013;132(8):1962–3.CrossRefPubMed
9.
Yang Y, Jiao Y. Authors’ reply to comments on a recent meta-analysis: obesity and lung cancer. Int J Cancer. 2013;132(8):1964–5.CrossRefPubMed
10.
Shen N, Fu P, Cui B, Bu C-Y, Bi J-W. Associations between body mass index and the risk of mortality from lung cancer: a dose–response PRISMA-compliant meta-analysis of prospective cohort studies. Med. 2017;96(34):e7721.CrossRef
11.
Yang Y, Dong J, Sun K, Zhao L, Zhao F, Wang L, Jiao Y. Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer. 2013;132(5):1162–9.CrossRefPubMed
12.
Duan P, Hu C, Quan C, Yi X, Zhou W, Yuan M, Yu T, Kourouma A, Yang K. Body mass index and risk of lung cancer: systematic review and dose-response meta-analysis. Sci Rep. 2015;5:16938.CrossRefPubMedPubMedCentral
13.
El-Zein M, Parent ME, Nicolau B, Koushik A, Siemiatycki J, Rousseau MC. Body mass index, lifetime smoking intensity and lung cancer risk. Int J Cancer. 2013;133(7):1721–31.CrossRefPubMed
14.
Gupta A, Majumder K, Arora N, Mayo HG, Singh PP, Beg MS, Hughes R, Singh S, Johnson DH. Premorbid body mass index and mortality in patients with lung cancer: a systematic review and meta-analysis. Lung Cancer. 2016;102:49–59.CrossRefPubMed
15.
Zhang X, Liu Y, Shao H, Zheng X. Obesity paradox in lung Cancer prognosis: evolving biological insights and clinical implications. J Thorac Oncol. 2017;12(10):1478–88.CrossRefPubMed
16.
Lam VK, Bentzen SM, Mohindra P, Nichols EM, Bhooshan N, Vyfhuis M, Scilla KA, Feigenberg SJ, Edelman MJ, Feliciano JL. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC). Lung Cancer. 2017;104:52–7.CrossRefPubMed
17.
18.
Gláucia F. Cota, Marcos R. de Sousa, Tatiani Oliveira Fereguetti, Ana Rabello. Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison. PLOS Negl Trop Dis. 2013;7(5):e2195.
19.
Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27(7):954–70.CrossRefPubMed
20.
21.
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.CrossRefPubMed
22.
Orsini NBR, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2009;6(1):17.
23.
Xiang Y, Gao Y, Zhong L, Jin F, Sun L, Cheng J, Zhai Y. A case-control study on relationship between body mass index and lung cancer in non-smoking women. Zhonghua Yu Fang Yi Xue Za Zhi. 1999;33(1):9–12.PubMed
24.
Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, et al. Body mass index and cancer incidence:a prospective cohort study in northern China. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35(3):231–6.PubMed
25.
Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol. 2008;26(20):3395–402.CrossRefPubMed
26.
Smith L, Brinton LA, Spitz MR, Lam TK, Park Y, Hollenbeck AR, Freedman ND, Gierach GL. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012;104(10):778–89.CrossRefPubMedPubMedCentral
27.
Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13(12):2241–7.CrossRefPubMed
28.
Li X, Bai Y, Wang S, Nyamathira SM, Zhang X, Zhang W, Wang T, Deng Q, He M, Wu T, et al. Association of body mass index with chromosome damage levels and lung cancer risk among males. Sci Rep. 2015;5:9458.CrossRefPubMedPubMedCentral
29.
30.
Kondo T, Hori Y, Yatsuya H, Tamakoshi K, Toyoshima H, Nishino Y, Seki N, Ito Y, Suzuki K, Ozasa K, et al. Lung cancer mortality and body mass index in a Japanese cohort: findings from the Japan collaborative cohort study (JACC study). Cancer Causes Control. 2007;18(2):229–34.CrossRefPubMed
31.
Radoi L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Tarnaud C, Menvielle G, Schmaus A, Cenee S, Carton M, et al. Body mass index, body mass change, and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study. Cancer Causes Control. 2013;24(7):1437–48.CrossRefPubMed
32.
Cui G, Staron MM, Gray SM, Ho PC, Amezquita RA, Wu J, Kaech SM. IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell. 2015;161(4):750–61.CrossRefPubMedPubMedCentral
33.
Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8(4):605–15.CrossRefPubMed
34.
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–6.CrossRefPubMedPubMedCentral
35.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134.CrossRefPubMedPubMedCentral
Metadata
Title
Body mass index and lung cancer risk in never smokers: a meta-analysis
Authors
Hongjun Zhu
Shuanglin Zhang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4543-y

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala

Research article

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

Research article

Association of tamoxifen resistance and lipid reprogramming in breast cancer

Research article

A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study

Research article

Prevalence of Mouse Mammary Tumor Virus (MMTV)-like sequences in human breast cancer tissues and adjacent normal breast tissues in Saudi Arabia

Research article

Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits